Neurobiology of Aging
Volume 29, Issue 5 , Pages 707-715 , May 2008

Degradation of fibrillar forms of Alzheimer's amyloid β-peptide by macrophages

  • Amitabha Majumdar

      Affiliations

    • Department of Biochemistry, Weill Medical College of Cornell University, New York, NY 10021, United States
    • These two authors contributed equally to this work.
    • ,
  • Haeyong Chung

      Affiliations

    • Department of Biochemistry, Weill Medical College of Cornell University, New York, NY 10021, United States
    • Department of Pathology, Columbia University-College of Physicians and Surgeons, New York, NY 10032, United States
    • These two authors contributed equally to this work.
    • ,
  • Georgia Dolios

      Affiliations

    • Department of Human Genetics, Mt. Sinai School of Medicine, New York, NY 10029, United States
    • ,
  • Rong Wang

      Affiliations

    • Department of Human Genetics, Mt. Sinai School of Medicine, New York, NY 10029, United States
    • Corresponding Author InformationCo-corresponding author.
    • ,
  • Nikiya Asamoah

      Affiliations

    • Department of Biochemistry, Weill Medical College of Cornell University, New York, NY 10021, United States
    • ,
  • Peter Lobel

      Affiliations

    • Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Piscataway, NJ 00854, United States
    • ,
  • Frederick R. Maxfield

      Affiliations

    • Department of Biochemistry, Weill Medical College of Cornell University, New York, NY 10021, United States
    • Corresponding Author InformationCorresponding author at: Weill Medical College of Cornell University, Department of Biochemistry, 1300 York Avenue, Room E215, New York, NY 10021, United States. Tel.: +1 212 746 6405; fax: +1 212 746 8875.

Received 14 July 2006 ,Revised 14 November 2006 ,Accepted 3 December 2006.

References 

  1. Akiyama H, Schwab C, Kondo H, Mori H, Kametani F, Ikeda K, et al. Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein. Neurosci. Lett. 1996;206(2–3):169–172
  2. Antzutkin ON, Leapman RD, Balbach JJ, Tycko R. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry. 2002;41(51):15436–15450
  3. Bacskai BJ, Kajdasz ST, Christie RH, Carter C, Games D, Seubert P, et al. Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 2001;7(3):369–372
  4. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 2000;6(8):916–919
  5. Barton NW, Furbish FS, Murray GJ, Garfield M, Brady RO. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc. Natl. Acad. Sci. U.S.A. 1990;87(5):1913–1916
  6. Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. U.S.A. 1993;90(5):2092–2096
  7. Chung H, Brazil MI, Soe TT, Maxfield FR. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J. Biol. Chem. 1999;274(45):32301–32308
  8. Dahms NM, Lobel P, Kornfeld S. Mannose 6-phosphate receptors and lysosomal enzyme targeting. J. Biol. Chem. 1989;264(21):12115–12118
  9. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005;8(6):752–758
  10. Forman MS, Trojanowski JQ, Lee VM. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 2004;10(10):1055–1063
  11. Frackowiak J, Wisniewski HM, Wegiel J, Merz GS, Iqbal K, Wang KC. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol. (Berl.). 1992;84(3):225–233
  12. Ghosh P, Dahms NM, Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell. Biol. 2003;4(3):202–212
  13. Kheterpal I, Williams A, Murphy C, Bledsoe B, Wetzel R. Structural features of the Abeta amyloid fibril elucidated by limited proteolysis. Biochemistry. 2001;40(39):11757–11767
  14. Kyttala A, Heinonen O, Peltonen L, Jalanko A. Expression and endocytosis of lysosomal aspartylglucosaminidase in mouse primary neurons. J. Neurosci. 1998;18(19):7750–7756
  15. Lin L, Lobel P. Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis. Biochem. J. 2001;357(Pt 1):49–55
  16. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314–1318
  17. Paresce DM, Chung H, Maxfield FR. Slow degradation of aggregates of the Alzheimer's disease amyloid β-protein by microglial cells. J. Biol. Chem. 1997;272(46):29390–29397
  18. Paresce DM, Ghosh R, Maxfield FR. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 1996;17:553–565
  19. Pessac B, Godin I, Alliot F. Microglia: origin and development. Bull. Acad. Natl. Med. 2001;185(2):337–346(discussion 46–47)
  20. Petkova AT, Buntkowsky G, Dyda F, Leapman RD, Yau WM, Tycko R. Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide. J. Mol. Biol. 2004;335(1):247–260
  21. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, et al. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. U.S.A. 2002;99(26):16742–16747
  22. Rogers J, Lue LF. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 2001;39(5–6):333–340
  23. Saido TC, Iwatsubo T, Mann DMA, Shimada H, Ihara Y, Kawashima S. Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3 (pE), in senile plaques. Neuron. 1995;14:457–466
  24. Sakr SW, Eddy RJ, Barth H, Wang F, Greenberg S, Maxfield FR, et al. The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity. J. Biol. Chem. 2001;276(40):37649–37658
  25. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse. Nature. 1999;400:173–177
  26. Schiffmann R, Murray GJ, Treco D, Daniel P, Sellos-Moura M, Myers M, et al. Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc. Natl. Acad. Sci. U.S.A. 2000;97(1):365–370
  27. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RCA, Younkin SG, Brunden KR. Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol. Aging. 1995;16(5):737–745
  28. Sleat DE, Lackland H, Wang Y, Sohar I, Xiao G, Li H, et al. The human brain mannose 6-phosphate glycoproteome: a complex mixture composed of multiple isoforms of many soluble lysosomal proteins. Proteomics. 2005;5(6):1520–1532
  29. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. New Engl. J. Med. 1989;320(14):915–924
  30. Wang R, Sweeney D, Gandy SE, Sisodia SS. The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 1996;271(50):31894–31902
  31. Wegiel J, Imaki H, Wang KC, Wronska A, Osuchowski M, Rubenstein R. Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice. Acta Neuropathol. (Berl.). 2003;105(4):393–402
  32. Wegiel J, Wang KC, Imaki H, Rubenstein R, Wronska A, Osuchowski M, et al. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP (SW) mice. Neurobiol. Aging. 2001;22(1):49–61
  33. Wisniewski HM, Wen GY, Kim KS. Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol. (Berl.). 1989;78(1):22–27
  34. Wisniewski T, Ghiso J, Frangione B. Review: biology of Aβ amyloid in Alzheimer's disease. Neurobiol. Dis. 1997;4:313–328
  35. Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein SC, Loike JD. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc. Natl. Acad. Sci. U.S.A. 1988;85(20):7734–7738

PII: S0197-4580(06)00459-3

doi: 10.1016/j.neurobiolaging.2006.12.001

Neurobiology of Aging
Volume 29, Issue 5 , Pages 707-715 , May 2008

Article Tools

* Image Usage & Resolution